Statements and Guidelines
The College's statements and guidelines inform the highest standard of clinical practice by our specialists. Request an Archived Document| Title | Notes | Category | Type | View | hf:tax:statement-guideline-type | hf:doc_categories |
|---|---|---|---|---|---|---|
| A Practitioner’s Toolkit for Managing Menopause (Monash University) | Gynaecology | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines | ||
| Altruistic and Directed Umbilical Cord Blood Banking for Families at Risk (C-Obs 18) | 2020 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Antenatal Corticosteroids Given to Women Prior to Birth to Improve Fetal, Infant, Child and Adult Health (Liggins Institute) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Assessment of Competency (C-Gen 9) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Attributes of a RANZCOG Fellow (C-Gen 19) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Birth After Previous Caesarean Section (C-Obs 38) | Under Review 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Caesarean Birth on Maternal Request CBMR (C-Obs 39) | 2023 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Care in Labour in the Absence of Pregnancy Complications (C-Obs 31) | 2023 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Categorisation of Urgency for Caesarean Section (C-Obs 14) | 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Cervical Cancer Screening in Australia and Aotearoa New Zealand (C-Gyn 19) | Signposting 2024 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Clinical Guideline for Abortion Care | 2023 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Care Around Stillbirth and Neonatal Death Clinical Practice Guideline (Stillbirth CRE & PSANZ) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Clinical Handover (WPI 19) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Clinical Training Whilst Pregnant (C-Trg 7) | Training | RANZCOG Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | ||
| Communication Between Eligible Midwives and Obstetricians (GP or Specialist) (ACM) | General | Relevant External Resource | useful-clinical-guidance | statements-guidelines-general statements-guidelines | ||
| Consent and Provision of Information to Patients in Australia Regarding Proposed Treatment (C-Gen 2a) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Consent and Provision of Information to Patients in New Zealand Regarding Proposed Treatment (C-Gen 2b) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Contraception Clinical Guideline (C-Gyn 3) | 2024 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Cross-Border Reproductive Care (C-Gyn 36) | 2021 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Credentialing in Obstetrics and Gynaecology (WPI 23) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Cultural Competency (WPI 20) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Delivery of Fetus at Caesarean Birth (C-Obs 37) | 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Decision Aids to Accompany Fatigue Risk Management in Obstetric and Gynaecological Practice (WPI 18) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Cultural Safety Statement of Intent | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Diagnosis and Management of Suspected Fetal Macrosomia (C-Obs 65) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Diagnosis of Gestational Diabetes Mellitus (GDM) (C-Obs 7) | Under Review 2017 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Early Pregnancy Screening and Prevention of Preterm Preeclampsia and Related Complications (C-Obs 61) | 2024 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Driving after Abdominal Surgery Including Caesarean Section (C-Gen 21) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Australian Living Evidence Guideline: Endometriosis | 2025 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Exercise During Pregnancy (C-Obs 62) | 2020 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Fatigue Risk Management in Obstetric and Gynaecological Practice (WPI 18) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Evidence-based Medicine, Obstetrics and Gynaecology (C-Gen 15) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Fetal Growth Restriction: Screening, Diagnosis, and Management in Singleton Pregnancies (SOGC) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Female Genital Mutilation (FGM) (C-Gyn 1) | 2023 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Genetic Carrier Screening (C-Obs 63) | Interim Update Jul 2024 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Fibroids in Infertility (C-Gyn 27) | 2018 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Guidance for Healthy Weight Gain in Pregnancy (Ministry of Health NZ) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Guidelines for Human Papillomavirus (HPV) Vaccine (C-Gyn 18) | Signposting 2024 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Guidelines for Appointment of Obstetricians and Gynaecologists to Specialist Positions in Australia and New Zealand (WPI 17) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Guidelines for the Use of Rh(D) Immunoglobulin (Anti-D) in Obstetrics (C-Obs 6) | 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Guidelines for Performing Gynaecological Endoscopic Procedures (C-Trg 2) | Training | RANZCOG Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | ||
| Guidelines for Patient Record Management on the Discontinuation of Practice (WPI 8) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Guidelines for Scanning of Live Subjects for Teaching Purposes (WPI 21) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Gynaecological Examinations and Procedures (C-Gyn 30) | 2020 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Guidelines for Training in Advanced Endoscopic Surgery (C-Trg 1) | Training | RANZCOG Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | ||
| Guidelines for Visiting Surgeons Conducting Demonstration Sessions (C-Gen 6) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Home Births (C-Obs 2) | 2023 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Instrumental Vaginal Birth (C-Obs 16) | 2020 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Intrahepatic Cholestasis of Pregnancy (RCOG Green-top Guideline No. 43) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Interview and Selection of Obstetricians and Gynaecologists for Visiting Medical Officers, Salaried Medical Officers and Academic Staff in Australia (WPI 4) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Intrapartum Fetal Surveillance Clinical Guideline (4th Edition) | Under Review 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Intrapartum Fetal Surveillance Clinical Guideline (Clinical Algorithm) | Under Review | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Investigation of Intermenstrual and Postcoital Bleeding (C-Gyn 6) | 2021 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Joint RANZCOG/ANZCA/RACGP Position Statement on the Provision of Obstetric Anaesthesia and Analgesia Services (WPI 14) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Locum Positions in Specialist Obstetric and Gynaecological Practice in Australia and New Zealand (WPI 12) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Management of Breech Presentation (C-Obs 11) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Management of Gestational Trophoblastic Disease (C-Gyn 31) | 2017 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Management of Hepatitis C in Pregnancy (C-Obs 51) | 2020 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Management of Monochorionic Twin Pregnancy (C-Obs 42) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Management of Obesity in Pregnancy (C-Obs 49) | 2022 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Management of Perinatal Infections (ASID) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Management of Postpartum Haemorrhage (PPH) (C-Obs 43) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Managing Menopausal Symptoms (C-Gyn 9) | Under Review 2020 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Maternal and Perinatal Data Collection (C-Obs 40) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Maternal Group B Streptococcus in Pregnancy Screening and Management (C-Obs 19) | 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Managing the Adnexa at the Time of Hysterectomy for Benign Gynaecological Disease (C-Gyn 25) | 2023 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Measurement of Cervical Length for Prediction of Preterm Birth (C-Obs 27) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Obstetric and Gynaecology Services in Rural and Remote Regions in Australia (C-Obs 34) | 2020 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Placenta Accreta Spectrum (PAS) (C-Obs 20) | 2023 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (PCOS) | Gynaecology | Relevant External Resource | useful-clinical-guidance | statements-guidelines-gynaecology statements-guidelines | ||
| Performance of Sexual Assault Forensic Examinations by RANZCOG Trainees (C-Gen 12) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Polypropylene Vaginal Mesh Implants for Vaginal Prolapse (C-Gyn 20) | 2021 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Position Statement on Midurethral Slings (C-Gyn 32) | 2020 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Position Statement on Breastfeeding and Lactation in the Workplace | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Position Statement on Robotic-assisted Laparoscopy (C-Gyn 29) | Under Review 2017 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Power Morcellation at Minimally Invasive Procedures (C-Gyn 33) (Previously “Tissue Extraction”) | 2022 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Position Statement on the Appropriate Use of Diagnostic Ultrasound (C-Gen 10) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Pre-Pregnancy and Pregnancy Related Vaccinations (C-Obs 44) | Signposting Interim Update Oct 2024 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Pre-Pregnancy Counselling (C-Obs 3a) | 2024 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Prevention and Management of Postpartum Haemorrhage (RCOG Green-top Guideline No. 52) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Prevention of Congenital Cytomegalovirus (CMV) Infection (C-Obs 64) | Interim Update July 2023 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Prevention, Detection, and Management of Subgaleal Haemorrhage in the Newborn (C-Obs 28) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Progesterone Use in the Second and Third Trimester of Pregnancy for the Prevention of Preterm Birth (C-Obs 29b) | 2017 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Prophylactic Antibiotics in Obstetrics and Gynaecology (C-Gen 17) | 2021 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| RANZCOG Training Registrar Supervision Guideline (C-Trg 5) | Training | RANZCOG Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | ||
| RANZCOG Position Statement Health of Women Seeking Asylum, Refugees and Women Held in Detention | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| RANZCOG Wellbeing Position Statement | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Responsibility for Neonatal Resuscitation at Birth (C-Obs 32) | Interim Update Mar 2023 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Reproductive Health for Women with an Intellectual Disability (C-Gyn 10) | 2021 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Routine Antenatal Assessment in the Absence of Pregnancy Complications (C-Obs 3b) | 2022 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Screening and Diagnosis of Fetal Structural Anomalies and Chromosome Conditions (C-Obs 35) | 2024 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Sacrocolpopexy Clinical Guidance Statement (C-Gyn 37) | 2022 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Shoulder Dystocia (RCOG Green-top Guideline No. 42) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Semi-Retired RANZCOG Fellow (WPI 24) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Shared Maternity Care in Australia (WPI 9) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Sexuality-Related Communication (WHO) | General | Relevant External Resource | useful-clinical-guidance | statements-guidelines-general statements-guidelines | ||
| Stand-Alone Primary Midwifery-Led Units (WPI 15) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | ||
| Statement on Climate Change (2019) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Statement on Prolonged Exposure to Bushfire Smoke and Poor Air Quality (2020) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Subclinical Hypothyroidism and Hypothyroidism in Pregnancy (C-Obs 46) | 2022 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Substance Use in Pregnancy Clinical Guideline (C-Obs 53) | 2024 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Term Prelabour Rupture of Membranes (Term PROM) (C-Obs 36) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Tamoxifen and the Endometrium (C-Gyn 12) | 2019 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Surrogacy in Australia and New Zealand (C-Gen 16) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| The Initial Management of Chronic Pelvic Pain (RCOG Green-top Guideline No. 41) | Gynaecology | Relevant External Resource | useful-clinical-guidance | statements-guidelines-gynaecology statements-guidelines | ||
| The Management of Third and Fourth Degree Perineal Tears (RCOG Green-top Guideline No. 29) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| The Management of Women with Red Cell Antibodies During Pregnancy (RCOG Green-top Guideline No. 65) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| The Prevention and Elimination of Disrespect and Abuse During Facility-based Childbirth (WHO) | General | Relevant External Resource | useful-clinical-guidance | statements-guidelines-general statements-guidelines | ||
| Third Trimester Fetal Growth Scan Reporting Template | 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Timing of Planned Caesarean Section at Term (C-Obs 23) | 2022 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| The RANZCOG Expert Witness Register & Guidelines for College Members Providing Expert Opinion (C-Gen 1) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | ||
| Umbilical Cord Prolapse (RCOG Green-top Guideline No. 50) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | ||
| Use of Prostaglandins for Induction of Labour (C-Obs 22) | 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Use of Lasers in Obstetrics and Gynaecology (C-Trg 4) | Training | RANZCOG Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | ||
| Use of the Veress Needle to Obtain Pneumoperitoneum Prior to Laparoscopy (C-Gyn 7) | 2021 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Uterine Artery Embolisation for the Treatment of Uterine Fibroids (C-Gyn 23) | 2020 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Vaginal Rejuvenation and Cosmetic Vaginal Procedures (C-Gyn 24) | 2019 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Vasa Praevia (C-Obs 47) | Under Review 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Vitamin and Mineral Supplementation and Pregnancy (C-Obs 25) | 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Water Immersion During Labour and Birth (C-Obs 24) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | |
| Miscarriage, Recurrent Miscarriage and Ectopic Pregnancy (C-Gyn 38) | 2025 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | |
| Early Pregnancy GDM Screening Recommendations (ADIPS) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Guideline on the Prophylactic Use of Rh-D Immunoglobin in Pregnancy Care | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Perinatal Mental Health Clinical Practice Guideline (Centre of Perinatal Excellence – COPE) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Position Statement: Reusable Surgical Gowns (Royal Australasian College of Surgeons) | Gynaecology, Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines-obstetrics statements-guidelines | ||
| Clinical Guideline: Smoking Cessation in Pregnancy and Breastfeeding (Quit Victoria) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Hypertension in Pregnancy Guideline (SOMANZ) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Guideline on Procedural Sedation (ANZCA) | Gynaecology, Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines-obstetrics statements-guidelines | ||
| Position Statement: Management of Sickle Cell Disease in Pregnancy (NSW Health) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Cervical Screening Guidelines and Endorsement (Cancer Council Australia) | Gynaecology | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines | ||
| Testing for, Diagnosing and Managing Gestational Diabetes (Diabetes of Pregnancy) (Health New Zealand – Te Whatu Ora) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Managing Infant Formula Donations, Procurement and Distribution in Emergencies (Australian Breastfeeding Association) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Vitamin D Deficiency Guideline (Te Whatu Ora) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| National Recommendations for Rare Disease Health Care (Rare Disease Awareness, Education, Support and Training RArEST Project) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Australian Evidence-Based Guideline for Unexplained Infertility (NHMRC) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Clinical Indications for Pharmacogenomic Testing (RCPA) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Guideline for Newborn Screening for Spinal Muscular Atrophy (UNSW) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| National AUB Guideline Endorsement (Health New Zealand – Te Whatu Ora) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| ARF/RHD Guidelines (Menzies School for Health Research) | Gynaecology | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines | ||
| Premature Ovarian Insufficiency Guideline (ESHRE) | Gynaecology | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines | ||
| Anti-Mullerian Hormone (AMH) Testing (University of Sydney) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines |
Disclaimer
RANZCOG reviews clinical guidelines, statements, and patient information pamphlets on a five-year rotation, notwithstanding special circumstances. The number of documents that require review in any given year is large and on occasion we are unable to complete all of them within the designated time frame. Some of these documents will not require updating at the time they are reviewed. In these cases, the version date and year for next review will be updated, but the content remains unchanged.
The ‘due for review date’ on a document is an administrative tool that helps us to keep track of our information resources. It does not mean that the information is no longer relevant once the review date has passed. The information within these documents does not expire, but changes to treatments, practices and advice can change over time, which is why RANZCOG regularly reviews and updates them (if necessary). The information provided in these documents is of a general nature and should not be seen as a substitute for medical advice or assessment by a doctor. An individual’s specific circumstances should always be considered when medical decisions are made.
RANZCOG will prioritise information for review if the circumstances warrant it.
Request archived documents
Complete the request form for archived statements and guidelines. Please note that requests can take 5-10 days to complete.